Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | COO | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,554 |
Reported balance
After 2026-08-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-20 · Tax withholding · Disposed 762 · Balance 28,554 F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.
F2: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 24, 2026 23:04 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Tax withholdingCommon Stock | 762 | $78.00 | $59,436.00 |
DisclosureSEC source: 0001193125-26-363888 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,554 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| May 20, 2026 Filed Jun 22, 2026 20:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Tax withholdingCommon Stock | 762 | $62.24 | $47,426.88 |
DisclosureSEC source: 0001193125-26-277646 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,316 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 19,436 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 20:41 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 662 | $78.86 | $52,205.32 |
DisclosureSEC source: 0001193125-26-104315 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,078 F1 · price: The price reported ($78.86) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $78.82 to $79.82 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 21,384 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:38 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1 | $78.52 | $78.52 |
DisclosureSEC source: 0001193125-26-102296 · ownership.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 0 Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 20:38 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,807 | $82.25 | $148,625.75 |
DisclosureSEC source: 0001193125-26-102296 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 1 Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:42 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072703 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,740 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028, and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates. F2 · balance_after: Includes 23,348 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,964 shares will vest on March 6, 2026; 1,948 shares will vest on each of May 20, 2026, August 20, 2026, November 20, 2026; 1,956 shares will vest on March 6, 2027; 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 1,640 shares will vest on March 6, 2028; 1,130 shares will vest on each of May 20, 2028, August 20, 2028, November 20, 2028; 1,134 shares will vest on March 6, 2029; 624 shares will vest on each of May 20, 2029, August 20, 2029, November 20, 2029 and the remaining 640 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:08 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 743 | $71.01 | $52,760.43 |
DisclosureSEC source: 0001193125-25-297192 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,740 F1 · price: The price reported $71.01 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $71.01 to $71.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 13,348 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| August 21, 2025 Filed Aug 21, 2025 23:54 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 763 | $84.97 | $64,832.11 |
DisclosureSEC source: 0000950170-25-110761 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,483 F1 · price: The price reported $84.97 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $84.90 to $85.02 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 15,296 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on November 20, 2025. 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 01:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,792 | $86.57 | $155,133.44 |
DisclosureSEC source: 0000950170-25-107551 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,246 F1 · balance_after: Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:30 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 530 | $78.08 | $41,382.40 |
DisclosureSEC source: 0000950170-25-076382 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,244 F1 · price: The price reported is the weighted average price ($78.08) . The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| March 07, 2025 Filed Mar 8, 2025 01:30 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,730 | $82.11 | $142,050.30 |
DisclosureSEC source: 0000950170-25-035831 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 7,168 F1 · shares: All 1,730 shares were sold at the same price of $82.11. F1 · price: All 1,730 shares were sold at the same price of $82.11. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 01:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 8,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028166 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,192 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments of 506 shares vesting on each of May 20, August 20, November 20 and March 6 in each year 2025, 2026, 2027 and 2028, with the final 510 shares vesting on March 6, 2029, if he is employed by the Company on those dates. F2 · balance_after: Includes the shares noted in footnote 1 and 11,092, shares described in next sentences. On February 24, 2025, the issuer and the reporting person mutually agreed to amend the vesting terms of the outstanding awards. Per the amendment, of the total outstanding unvested shares of 11,092, 1,442 will vest on May 20, 2025, August 20, 2025 and November 20, 2025, 1,458 will vest on March 6, 2026, 818 will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 826 will vest on March 6, 2027, 506 will vest on each of May 20, 2027, August 20, 2027, November 2027 and 510 will vest on March 6, 2028, if he is employed on those dates. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,724 | $96.29 | $166,003.96 |
DisclosureSEC source: 0000950170-24-125739 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 7,106 Read SEC document |
| August 21, 2024 Filed Aug 21, 2024 21:49 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,724 | $82.50 | $142,230.00 |
DisclosureSEC source: 0000950170-24-099579 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 7,038 F1 · price: The reported price is the weighted average price. The reporting person undertakes to provide to U.S. Physical Therapy Inc., any of its shareholders or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold each at each separate price on this footnote Form 4. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,724 | $105.46 | $181,813.04 |
DisclosureSEC source: 0000950170-24-059850 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 6,970 F1 · price: The price reported ($105.46) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $105.44 to $105.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:28 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,629 | $104.39 | $274,441.31 |
DisclosureSEC source: 0000950170-24-026491 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 6,902 F1 · price: This price is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.12 to $104.74 per share, both inclusive. The reporting person undertakes to provide U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set fort in this footnote to this Form 4. Read SEC document |
| February 26, 2024 Filed Feb 29, 2024 01:26 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 8,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022520 · ownership.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,260 F1 · shares: The 8,100 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 506 shares vesting on April 1, 2024 thereafter 506 shares on April 1, July 1, October 1 and January 1 of each year with the final 510 shares lapsong on Janaury 1, 2028 if he is employed by the Company on those dates. F2 · balance_after: Includes 18,260 shares, inclusive of those shares mentioned in note1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,792 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 1,793 shares on January 1, 2025; 1,442 shares on each of April 1, 2025, July 1, 2025, October 1, 2025; 1,459 shares on January 1, 2026; 818 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:42 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,500 | $87.39 | $131,085.00 |
DisclosureSEC source: 0001209191-23-055567 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 7,801 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.02 to $87.54, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:59 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 4,114 | $109.99 | $452,498.86 |
DisclosureSEC source: 0001209191-23-045664 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: No plan indicated Ownership: Indirect · Reeve Trust Disclosed balance after: 7,577 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.27 to $111.14, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:11 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,912 | $100.95 | $193,016.40 |
DisclosureSEC source: 0001209191-23-016252 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 8,243 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.73 to $101.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 21:37 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012208 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,062 F1 · shares: The 5,000 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installments with 312 shares vesting on the first day of each of the succeeding fifteen quarters beginning on April 1, 2023, and with the final 320 shares vesting on January 1, 2027, if he is employed by the Company on those dates. F2 · balance_after: Includes 17,062 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,724 shares on each of April 1, 2023, July 1, 2023, October 1, 2023; 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025; 936 shares on each of April 1, 2025 July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:47 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,909 | $84.79 | $161,864.11 |
DisclosureSEC source: 0001209191-22-056112 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 8,083 F1 · price: The price reported is a weighted average price $84.79 The shares were purchased in multiple transactions at prices ranging from $84.55 to $85.00 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 16:36 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 3,818 | $92.24 | $352,172.32 |
DisclosureSEC source: 0001209191-22-045144 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,191 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $92.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 16,191 shares which restrictions lapse as to 2,057 shares on October 1, 2022; 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1, and October 1, 2023; 1,418 shares on January 1, 2024; and 974 shares on each of April 1, July 1, and October 1, 2024; 974 shares on January 1, 2025; and 624 shares on April 1, July 1, October 1, 2025 with the final 640 shares lapsing on January 1, 2026 if he is still employed by the Company on those dates. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 14:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018694 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,305 F1 · shares: The 10,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 624 shares on April 1, 2022 and thereafter with 624 shares on April 1, July 1, October 1 and January 1 of each year with the final 640 shares lapsing on January 1, 2026, if he is employed by the Company on those dates. F2 · balance_after: Includes the 10,000 shares in Footnote 1 and includes 10,305 shares which restrictions lapse as to 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates. Also includes 7,639 shares held in a trust in which Mr. Reeve is trustee and beneficiary. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 16:22 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon StockCommon Stock | 2,118 | $90.75 | $192,208.50 |
DisclosureSEC source: 0001209191-22-014493 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 7,639 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.68 - $91.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 15:42 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $94.19 | $94,190.00 |
DisclosureSEC source: 0001209191-21-068262 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve trust Disclosed balance after: 7,845 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.00 to $94.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 22:23 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,559 | $114.15 | $177,959.85 |
DisclosureSEC source: 0001209191-21-050678 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 6,936 F2 · price: The price reported is a weighted average price ($114.15). The shares were sold in multiple transactions at prices ranging from $113.96 to $114.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 07, 2021 Filed May 10, 2021 16:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,819 | $117.99 | $214,623.81 |
DisclosureSEC source: 0001209191-21-031177 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 6,586 F2 · price: The price reported is a weighted average price ($117.99). The shares were sold in multiple transactions at prices ranging from $117.97 to $118.20 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 17:05 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,200 | $116.50 | $139,800.00 |
DisclosureSEC source: 0001209191-21-015607 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 6,496 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 17:12 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013678 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,944 F1 · shares: The 5,600 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan of which 4,400 under the Companys Discretionary Long-Term Incentive Plan for Senior Management and 1,200 as an additional grant. Restrictions lapse in 16 equal quarterly installment with the first 350 shares on April 1, 2021 and thereafter with 350 shares on April 1, July 1, October 1 and January 1 of each year with the final 350 shares lapsing on January 1, 2025, if he is employed by the Company on those dates. F2 · balance_after: Inclusive of the above 5,600 shares in footnote 1, includes 17, 944 shares which restrictions lapse as to 1,909 shares on each of April 1, July 1 and October 1, 2021; 1,912 shares on January 1, 2022; 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 15:11 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $104.23 | $104,230.00 |
DisclosureSEC source: 0001209191-20-058216 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 6,137 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.86 to $104.59, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F3 · balance_after: Shares are held in the Reeve Living Trust which Mr. Reeve is a trustee and beneficiary. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 18:29 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,500 | $90.21 | $135,315.00 |
DisclosureSEC source: 0001209191-20-046749 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 5,578 F2 · balance_after: Shares are held in the Reeve Living Trust which Mr. Reeve is a trustee and beneficiary. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:03 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $78.35 | $78,350.00 |
DisclosureSEC source: 0001209191-20-033289 · doc4.xml · nonDerivative · entry 2 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 5,519 F2 · balance_after: Shares are held in the Reeve Living Trust, which Mr. Reeve is a trustee and beneficiary. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:23 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 7,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016493 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,580 F1 · shares: The 7,014 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 438 shares on April 1, 2020 and thereafter with 438 shares on April 1, July 1, October 1 and January 1 of each year with the final 444 shares lapsing on January 1, 2024, if he is employed by the Company on those dates. F2 · balance_after: Includes 18,580 shares which restrictions lapse as to 1,559 shares on each of April 1, July 1 and October 1, 2020 and 2021; 1,562 shares on January 1, 2022; 1,083 shares on each of April 1, July 1 and October 1, 2022; 1,098 shares on January 1, 2023; 438 shares on each of April 1, July 1 and October 1 2023 and 444 shares on January 1, 2024, if he is employed by the Company on those dates. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 17:10 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 476 | $116.06 | $55,244.56 |
DisclosureSEC source: 0001209191-19-057902 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Indirect · Reeve Trust Disclosed balance after: 3,839 F1 · balance_after: Shares are held in the Reeve Living Trust, which Mr. Reeve is a trustee and beneficiary. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 18:08 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 952 | $134.00 | $127,568.00 |
DisclosureSEC source: 0001209191-19-045707 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,002 F1 · balance_after: Includes 13,808 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 1,121 shares on each of October 1, 2019, January 1, April 1, July1, October 1, 2020 and 2021; 1,124 shares on each of January 1, 2022; 645 shares on each of April 1, July 1 and October 1, 2022; 660 shares on January 1, 2023. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 22:13 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016720 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,954 F1 · shares: The 10,335 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 645 shares on April 1, 2019 and thereafter with 645 shares on April 1, July 1, October 1 and January 1 of each year with the final 660 shares lapsing on January 1, 2023. F2 · balance_after: Includes 16,050 shares, inclusive of the 10,335 shares in footnote 1, of restricted stock granted under the Company's equity plans. Restrictions lapse as to 1,121 shares on each of April 1, 2019, July 1, 2019, October 1, 2019, January 1, 2020, April 1, 2020, July 1, 2020, October 1, 2020, January 1, 2021, April 1, 2021, July 1, 2021 and October 1, 2021; and 1,124 shares on January 1, 2022; 645 on each of April 1, July 1 and October 1, 2022; and 660 on January 1, 2023. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 19:46 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 7,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017654 · doc4.xml · nonDerivative · entry 1 REEVE GRAHAM D. · CIK 0001519948 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,619 F1 · shares: The 7,619 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installment with the first 15 installments of 476 shares each beginning on April 1, 2018 and thereafter with 476 shares on April 1, July 1, October 1 and January 1 of each year with the final 479 shares lapsing on January 1, 2022. F2 · balance_after: See Note (1). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.